The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Transplantation-Global Market Insights and Sales Trends 2025
Synopsis
Transplantation is a procedure wherein diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore normal functioning of the body. Donor and recipient cells, tissues, and organs should match or be compatible, or can lead to transplant rejection. The surface of the transplanted organs contains antigens, which the recipient's immune system may not adapt to. This can lead to rejection of an organ. Hence, serological and human leukocyte antigen (HLAs) tests are conducted to help identify the antigens and help in successful organ transplantation. With HLA testing, immunosuppressive drugs are provided to minimize graft rejection. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.
The global Transplantation market size is expected to reach US$ 127920 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Transplantation in various end use industries. The expanding demands from the Hospitals and Transplant Centers and Diagnostic Registries and Research Laboratories, are propelling Transplantation market. Kidney Transplantation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liver Transplantation segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transplantation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transplantation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transplantation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transplantation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transplantation covered in this report include AbbVie, Arthrex, Zimmer Biomet, Medtronic, Novartis, Stryker, BioLifeSolutions, Teva Pharmaceuticals and Veloxis Pharmaceuticals, etc.
The global Transplantation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Arthrex
Zimmer Biomet
Medtronic
Novartis
Stryker
BioLifeSolutions
Teva Pharmaceuticals
Veloxis Pharmaceuticals
Global Transplantation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transplantation market, Segment by Type:
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation
Global Transplantation market, by Application
Hospitals and Transplant Centers
Diagnostic Registries and Research Laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transplantation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Transplantation is a procedure wherein diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore normal functioning of the body. Donor and recipient cells, tissues, and organs should match or be compatible, or can lead to transplant rejection. The surface of the transplanted organs contains antigens, which the recipient's immune system may not adapt to. This can lead to rejection of an organ. Hence, serological and human leukocyte antigen (HLAs) tests are conducted to help identify the antigens and help in successful organ transplantation. With HLA testing, immunosuppressive drugs are provided to minimize graft rejection. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.
The global Transplantation market size is expected to reach US$ 127920 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Transplantation in various end use industries. The expanding demands from the Hospitals and Transplant Centers and Diagnostic Registries and Research Laboratories, are propelling Transplantation market. Kidney Transplantation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liver Transplantation segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transplantation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transplantation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transplantation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transplantation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transplantation covered in this report include AbbVie, Arthrex, Zimmer Biomet, Medtronic, Novartis, Stryker, BioLifeSolutions, Teva Pharmaceuticals and Veloxis Pharmaceuticals, etc.
The global Transplantation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Arthrex
Zimmer Biomet
Medtronic
Novartis
Stryker
BioLifeSolutions
Teva Pharmaceuticals
Veloxis Pharmaceuticals
Global Transplantation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transplantation market, Segment by Type:
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation
Global Transplantation market, by Application
Hospitals and Transplant Centers
Diagnostic Registries and Research Laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transplantation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Transplantation
1.1 Transplantation Market Overview
1.1.1 Transplantation Product Scope
1.1.2 Transplantation Market Status and Outlook
1.2 Global Transplantation Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Transplantation Market Size by Region (2018-2029)
1.4 Global Transplantation Historic Market Size by Region (2018-2023)
1.5 Global Transplantation Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Transplantation Market Size (2018-2029)
1.6.1 North America Transplantation Market Size (2018-2029)
1.6.2 Europe Transplantation Market Size (2018-2029)
1.6.3 Asia-Pacific Transplantation Market Size (2018-2029)
1.6.4 Latin America Transplantation Market Size (2018-2029)
1.6.5 Middle East & Africa Transplantation Market Size (2018-2029)
2 Transplantation Market by Type
2.1 Introduction
2.1.1 Kidney Transplantation
2.1.2 Liver Transplantation
2.1.3 Heart Transplantation
2.1.4 Lung Transplantation
2.1.5 Pancreas Transplantation
2.2 Global Transplantation Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Transplantation Historic Market Size by Type (2018-2023)
2.2.2 Global Transplantation Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Transplantation Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Transplantation Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Transplantation Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Transplantation Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Transplantation Revenue Breakdown by Type (2018-2029)
3 Transplantation Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Transplant Centers
3.1.2 Diagnostic Registries and Research Laboratories
3.2 Global Transplantation Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Transplantation Historic Market Size by Application (2018-2023)
3.2.2 Global Transplantation Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Transplantation Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Transplantation Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Transplantation Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Transplantation Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Transplantation Revenue Breakdown by Application (2018-2029)
4 Transplantation Competition Analysis by Players
4.1 Global Transplantation Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transplantation as of 2022)
4.3 Date of Key Players Enter into Transplantation Market
4.4 Global Top Players Transplantation Headquarters and Area Served
4.5 Key Players Transplantation Product Solution and Service
4.6 Competitive Status
4.6.1 Transplantation Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Transplantation Products, Services and Solutions
5.1.4 AbbVie Transplantation Revenue (US$ Million) & (2018-2023)
5.1.5 AbbVie Recent Developments
5.2 Arthrex
5.2.1 Arthrex Profile
5.2.2 Arthrex Main Business
5.2.3 Arthrex Transplantation Products, Services and Solutions
5.2.4 Arthrex Transplantation Revenue (US$ Million) & (2018-2023)
5.2.5 Arthrex Recent Developments
5.3 Zimmer Biomet
5.3.1 Zimmer Biomet Profile
5.3.2 Zimmer Biomet Main Business
5.3.3 Zimmer Biomet Transplantation Products, Services and Solutions
5.3.4 Zimmer Biomet Transplantation Revenue (US$ Million) & (2018-2023)
5.3.5 Medtronic Recent Developments
5.4 Medtronic
5.4.1 Medtronic Profile
5.4.2 Medtronic Main Business
5.4.3 Medtronic Transplantation Products, Services and Solutions
5.4.4 Medtronic Transplantation Revenue (US$ Million) & (2018-2023)
5.4.5 Medtronic Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Transplantation Products, Services and Solutions
5.5.4 Novartis Transplantation Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Stryker
5.6.1 Stryker Profile
5.6.2 Stryker Main Business
5.6.3 Stryker Transplantation Products, Services and Solutions
5.6.4 Stryker Transplantation Revenue (US$ Million) & (2018-2023)
5.6.5 Stryker Recent Developments
5.7 BioLifeSolutions
5.7.1 BioLifeSolutions Profile
5.7.2 BioLifeSolutions Main Business
5.7.3 BioLifeSolutions Transplantation Products, Services and Solutions
5.7.4 BioLifeSolutions Transplantation Revenue (US$ Million) & (2018-2023)
5.7.5 BioLifeSolutions Recent Developments
5.8 Teva Pharmaceuticals
5.8.1 Teva Pharmaceuticals Profile
5.8.2 Teva Pharmaceuticals Main Business
5.8.3 Teva Pharmaceuticals Transplantation Products, Services and Solutions
5.8.4 Teva Pharmaceuticals Transplantation Revenue (US$ Million) & (2018-2023)
5.8.5 Teva Pharmaceuticals Recent Developments
5.9 Veloxis Pharmaceuticals
5.9.1 Veloxis Pharmaceuticals Profile
5.9.2 Veloxis Pharmaceuticals Main Business
5.9.3 Veloxis Pharmaceuticals Transplantation Products, Services and Solutions
5.9.4 Veloxis Pharmaceuticals Transplantation Revenue (US$ Million) & (2018-2023)
5.9.5 Veloxis Pharmaceuticals Recent Developments
6 North America
6.1 North America Transplantation Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Transplantation Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Transplantation Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Transplantation Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Transplantation Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Transplantation Market Dynamics
11.1 Transplantation Industry Trends
11.2 Transplantation Market Drivers
11.3 Transplantation Market Challenges
11.4 Transplantation Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
